title: Primary sclerosing cholangitis associated with lupus nephritis: a rare association.
authors.affiliation: Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Kadokawa
authors.forename: Katsuhisa
authors.initials: K
authors.lastname: Omagari
authors.forename: Isao
authors.initials: I
authors.lastname: Matsuo
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Otsu
authors.forename: Umpei
authors.initials: U
authors.lastname: Yamamoto
authors.forename: Tomoya
authors.initials: T
authors.lastname: Nishino
authors.forename: Kazuo
authors.initials: K
authors.lastname: Ohba
authors.forename: Masanobu
authors.initials: M
authors.lastname: Miyazaki
authors.forename: Takashi
authors.initials: T
authors.lastname: Harada
authors.forename: Takashi
authors.initials: T
authors.lastname: Taguchi
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kohno
mesh_terms: D001707:Biopsy, Needle; D015209:Cholangitis, Sclerosing / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007564:Japan; D008181:Lupus Nephritis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D035583:Rare Diseases; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
chemical_list: D014580:Ursodeoxycholic Acid; D011239:Prednisolone